Langerin (CD207) Mouse Monoclonal Antibody [Clone ID: 306G9.01/HD24]
CAT#: DDX0368B-100
Langerin (CD207) mouse monoclonal antibody, clone 306G9.01/HD24
Need it in bulk or conjugated?
Get a free quote
CNY 5,775.00
货期*
4周
规格
Specifications
Product Data | |
Clone Name | 306G9.01/HD24 |
Applications | FC, IHC |
Recommend Dilution | Flow cytometry, IF, IHC. Usage recommendation: *This monoclonal antibody may be used between 5-20 μg/ml *Optimal dilution should be determined by each laboratory for each application. *Coupled antibody: to maintain RT before using. |
Reactivity | Human, Mouse, Porcine, Rat |
Host | Mouse |
Clonality | Monoclonal |
Immunogen | Mouse langerin–transfected COP5 cells. |
Specificity | Mouse and Human Langerin (intracellular epitope). Species cross- reactivity: Human, Rat, Swine. |
Formulation | Purified: 100 μg in 200μl / 50 μg in 100 μl Tris-NaCl pH 8. Coupled: 100 μg in 200μl / 50 μg in 100 μl PBS 50% glycerol. Label: Biotin |
Concentration | lot specific |
Purification | QMA Hyper D ion exchange chromatography |
Conjugation | Biotin |
Storage Condition | -20°C. KEEP CONTENTS STERILE: no preservative. Purified antibodies: avoid repeated freeze/thaw cycles. Coupled antibodies: glycerol protects from freezing. |
Gene Name | CD207 molecule |
Database Link | |
Background | Langerin/CD207 is a transmembrane C-type lectin receptor (CLR) of epidermal and mucosal Langerhans cells (LCs) that induces Birbeck granule formation. Langerin features a single carbohydrate recognition domain (CRD) with mannose-type specificity in its extracellular portion. Langerin is unique among the CLRs in that it contains an intracellular domain with a proline-rich motif. Langerin expression has not been reported outside the DC system. In mouse, clone 306G9 stains lymph node dendritic cells (Henri et al, 2001, J. Immunol, 167: 741-748) (Valladeau J. et al, 2002 J Immunol, 168: 782). |
Synonyms | CLEC4K, Dendritic Cell Marker |
Reference Data |
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |
Customer
Reviews
Loading...